Profit Margin (Quarterly) Chart

View Profit Margin (Quarterly) for RVP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Profit Margin (Quarterly) Chart
Start Trial

Historical Profit Margin (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
June 30, 2026 39.31%
March 31, 2026 -58.87%
December 31, 2025 -24.88%
September 30, 2025 3.68%
June 30, 2025 -0.84%
March 31, 2025 -126.6%
December 31, 2024 41.56%
September 30, 2024 -18.58%
June 30, 2024 -234.9%
March 31, 2024 5.65%
December 31, 2023 -0.51%
September 30, 2023 -39.29%
June 30, 2023 -48.53%
March 31, 2023 9.01%
December 31, 2022 -33.77%
September 30, 2022 23.35%
June 30, 2022 -25.40%
March 31, 2022 17.02%
December 31, 2021 35.19%
September 30, 2021 17.94%
June 30, 2021 25.09%
March 31, 2021 35.86%
December 31, 2020 37.40%
September 30, 2020 41.16%
June 30, 2020 32.54%
Date Value
March 31, 2020 2.88%
December 31, 2019 14.74%
September 30, 2019 8.80%
June 30, 2019 4.08%
March 31, 2019 -1.63%
December 31, 2018 -1.81%
September 30, 2018 -0.64%
June 30, 2018 -12.68%
March 31, 2018 -2.34%
December 31, 2017 -11.88%
September 30, 2017 -0.64%
June 30, 2017 -17.65%
March 31, 2017 -17.19%
December 31, 2016 -26.35%
September 30, 2016 -1.42%
June 30, 2016 -8.67%
March 31, 2016 -15.86%
December 31, 2015 19.24%
September 30, 2015 -2.69%
June 30, 2015 95.88%
March 31, 2015 -15.28%
December 31, 2014 6.55%
September 30, 2014 3.41%
June 30, 2014 -20.21%
March 31, 2014 -33.75%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 7.37%
AngioDynamics, Inc. -13.17%
Alphatec Holdings, Inc. -12.07%
AtriCure, Inc. 5.83%
Baxter International, Inc. 4.56%